Simeon Kimmel MD, MA
Assistant Professor, General Internal Medicine
801 Massachusetts Ave | (617) 414-2846simeon.kimmel@bmc.org
sdkimmel@bu.edu

Sections
General Internal Medicine
Centers
Clinical Addiction Research and Education Unit
Biography
Simeon Kimmel is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and an Attending Physician in the Sections of General Internal Medicine and Infectious Diseases at Boston Medical Center and Medical Director of Project TRUST, Boston Medical Center’s harm reduction focused drop-in center. He trained in Internal Medicine and Primary Care at Brigham and Women’s Hospital before completing a joint fellowship in Addiction Medicine and Infectious Diseases at Boston Medical Center. He also earned a Master's Degree in Medical Anthropology from the Harvard Graduate School of Arts and Sciences. His research focuses on improving retention in treatment with medications for opioid use disorder following serious injection related infections as well as the integration of addiction and harm reduction services with infectious disease care. He was awarded a Career Development Award from NIDA in 2021.
Education
MD, Harvard Medical School
MA, Harvard Graduate School of Arts and Sciences
Publications
Paradise RK, Kimmel SD, Nurani A, Desmarais J, O'Malley S, Walley AY, Hoyos-Cespedes A, Clarke J, Taylor S, Dooley D, Bazzi AR. Building connection: overdose survivors' and professional service providers' perspectives on immediate post-overdose care. Int J Drug Policy. 2025 Aug 09; 145:104948. PMID: 40784254.
Published on 8/7/2025Christine PJ, Kimmel SD, Martin SA, Massad C, Walley AY. National Estimates of Opioid Overdose Hospitalizations Resulting in Hypoxic-ischemic Brain Injury. J Gen Intern Med. 2025 Aug 07. PMID: 40775114.
Published on 6/20/2025Ritter AZ, Roma C, Soske J, Merrick C, Kennedy KA, Nishar S, Kimmel S, Zullo AR, Dow PM. Optimizing care transitions to post-acute care following hospitalization for people with opioid use disorder. Innov Aging. 2025 Aug; 9(8):igaf069. PMID: 40919508.
Published on 4/3/2025Jayasinghe T, Drainoni ML, Walley A, Grella C, Majeski A, Rolles A, Cogan A, Venkatesan G, Stein MD, Larochelle M, Samet JH, Kimmel SD. "Every Time I Go in There, It Gives Me Time to Reflect": A Qualitative Study of Patient Perspectives on Substance Use, Medications for Opioid Use Disorder, and Harm Reduction Following Hospitalization for Serious Injection-Related Infection. Open Forum Infect Dis. 2025 May; 12(5):ofaf201. PMID: 40352630.
Published on 1/28/2025Benheim TS, Kimmel SD, George M, Dow PM. Readmissions and Mortality After "Before Medically Advised" Hospital Discharges Among Medicare Beneficiaries with Opioid Use Disorder. J Gen Intern Med. 2025 Jan 28. PMID: 39875771.
Published on 12/17/2024Bovell-Ammon BJ, Onofrey S, Kimmel SD, Wurcel AG, Klevens M. Incarceration history and HIV testing among people who inject drugs in the Boston metro area: a pooled cross-sectional study. Res Sq. 2024 Dec 17. PMID: 39764124.
Published on 11/8/2024Rosenmoss S, LaRochelle M, Bearnot B, Weinstein Z, So-Armah K, Moyo P, Yan S, Walley AY, Kimmel SD. Racial and Ethnic Disparities in Referral Rejection From Postacute Care Facilities Among People With Opioid Use Disorder in Massachusetts. J Addict Med. 2025 Mar-Apr 01; 19(2):165-171. PMID: 39514897.
Published on 10/8/2024Nishar S, Soske J, Vanjani R, Kimmel SD, Roma C, Dow PM. Access and care for people with opioid use disorder in U.S. skilled nursing facilities: A policy commentary. Int J Drug Policy. 2024 Nov; 133:104607. PMID: 39383611.
Published on 8/1/2024Christine PJ, Chahine RA, Kimmel SD, Mack N, Douglas C, Stopka TJ, Calver K, Fanucchi LC, Slavova S, Lofwall M, Feaster DJ, Lyons M, Ezell J, Larochelle MR. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements. JAMA Netw Open. 2024 Aug 01; 7(8):e2425999. PMID: 39102264.
Published on 7/30/2024Parbs JR, Srinivasan S, Pustz J, Bayly R, Shrestha S, Lewis O, Kimmel S, Meehan T, Babakhanlou-Chase H, Stopka TJ. The optimization of harm reduction services in Massachusetts through the use of GIS: Location-allocation analyses, 2019-2021. Prev Med. 2024 Sep; 186:108088. PMID: 39084414.
Media Mentions
Published on 8/3/2023
Published on 8/2/2023
Published on 7/5/2023
Long-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients
Published on 7/5/2023
Long-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients
Published on 6/22/2022
Published on 5/17/2022
BMC Pilots Training Program to Improve Post-Acute Care for Patients with Substance Use Disorder
Published on 5/10/2022
Published on 4/20/2022
COVID-19: Unionized Nursing Homes Showed Lower Resident Mortality Rates
Published on 3/11/2022
Published on 3/8/2022
Patients with opioid use disorder often rejected for skilled follow-up care, study finds
View full list of 21 media mentions.